TY - JOUR T1 - Chemoembolization in Colorectal Liver Metastases: The Rebirth JF - Anticancer Research JO - Anticancer Res SP - 575 LP - 584 VL - 34 IS - 2 AU - GIAMMARIA FIORENTINI AU - CAMILLO ALIBERTI AU - LUCA MULAZZANI AU - PAOLO COSCHIERA AU - VINCENZO CATALANO AU - DAVID ROSSI AU - PAOLO GIORDANI AU - STEFANO RICCI Y1 - 2014/02/01 UR - http://ar.iiarjournals.org/content/34/2/575.abstract N2 - Currently image-guided trans-arterial chemoembolization (TACE) has a significant role in the therapy of patients with hepatocellular carcinoma and liver metastases. This endovascular hepatic-directed therapy offers the dual benefit of true local neoplastic control and reduction of side-effects. As a result, it has been included in the guidelines for primary liver cancer and is often considered as salvage therapy for patients liver metastases from neuroendocrine and chemorefractory colorectal tumors. The development of new embolizing agents, such as DC beads loaded with doxorubicin and irinotecan, permits better standardization and definition of protocols, making the procedures less linked to criteria of different hospitals and personal experiences of interventional radiologists. The understanding that hypoxia induces vessel re-growth will open a new avenue for clinical research and a rebirth for TACE. Chemoembolization followed by target therapy (bevacizumab, aflibercept and regorafenib) could increase quality, duration of responses and better quality of life. ER -